Skip to main content
. 2021 Nov 26;10(12):1894. doi: 10.3390/antiox10121894

Table 1.

Clinical Trials.

Code N° Subjects Cancer Type Finding Ref.
NCT0272428 12,741 all ↓incidence in men (7,5 yr.) Hercber et al. [48]
NCT00270647 14,641 all ↓re-incidence in men (11 yr.) Gaziano et al. [49]
Eudra-CT2019-004074-25/
NCT01080352
20 prostate Media-severe side effects Nielsen et al. [52]
NCT0105062 14 all ↓symptoms/progression (43%) Hoffer et al. [54]
NCT00006021 22 myeloma ↓progression (50%) Bahlis et al. [55]
NCT01515046/
NCT01049880
9 pancreas ↑survival (12 mo.) Welsh et al. [56]
NCT01364805 14 pancreas ↓metastasis and cell proliferation Polireddy et al. [57]
NCT00954525 14 pancreas ↓tumor size Monti et al. [58]